# Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study

> **NCT02038348** · PHASE2 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 5 (estimated)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **DEVICE:** PET with 18F-FDOPA

## Key facts

- **NCT ID:** NCT02038348
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-16
- **Primary completion:** 2018-02-22
- **Final completion:** 2022-10-28
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02038348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02038348, "Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02038348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*